Telix Pharmaceuticals Limited: Czech Republic First European Country to Grant National Authorisation for the Use of Telix's Prostate Cancer Imaging Product
MELBOURNE, Australia and LIÈGE, Belgium, Feb. 16, 2021 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, 'Telix', the 'Company') announces today that the Ministry of Health of the Czech Republic